5th International Conference Integrative Chemistry, Biology & Translational Medicine
The conference will be held on 25-27 June 2026 in Debrecen. The journey of ICBTM began in 2019 with the
A forum for researchers, students and applicants in the field of cyclodextrin technology
The conference will be held on 25-27 June 2026 in Debrecen. The journey of ICBTM began in 2019 with the
This study investigates the PEG‑β‑CD polymer, a water‑soluble polyethylene glycol–β‑cyclodextrin cross‑linked carrier, as a potential alternative to conventional oestradiol formulations
Yeasts need to incorporate unsaturated fatty acids (UFA) into their membranes to maintain fluidity during low-temperature fermentation. .In typical white wine
The conference will be held on 25-27 June 2026 in Debrecen. The journey of ICBTM began in 2019 with the
This study investigates the PEG‑β‑CD polymer, a water‑soluble polyethylene glycol–β‑cyclodextrin cross‑linked carrier, as a potential alternative to conventional oestradiol formulations
Yeasts need to incorporate unsaturated fatty acids (UFA) into their membranes to maintain fluidity during low-temperature fermentation. .In typical white wine
Amorphous red phosphorus (ARP) has recently been identified as a zig-zag ladder polymer, yet its function beyond a low-cost phosphorus
The cochlea is the sensory organ responsible for hearing. Central to its sensory functions is the organ of Corti, a
Soy peptides (SPs) have been extensively studied with an emphasis on their immune-boosting effects and production-associated bitterness. This associated bitterness
The Materials Science and Engineering (MSE) Congress 2026 will be held from September 29 to October 1, 2026, in Darmstadt, Germany, as a
Previous studies have demonstrated that the solubility and biocompatibility of poorly water-soluble anti-cancer agents can be improved by complexation with
The aim of the present study was to complex the potent steroidal hormones progesterone (PRO) and 17β-estradiol (BES) with heptakis(2,6-di-O-methyl)-β-cyclodextrin
VYKOURA is a newly approved medication (marketing start date: 02/03/2026) containing leucovorin calcium, a prescription injectable drug used in hospital